Fundz

ImageneBio Appoints Kristin Yarema as Chief Executive Officer

PUBLIC · IMAAug 01, 2025

Position

Chief Executive Officer

Company

ImageneBio

Kristin Yarema
San DiegoBiotechnologyHealth CareTherapeuticsBiopharma

Description

ImageneBio granted equity awards to Dr. Kristin Yarema, who was recently appointed as Chief Executive Officer. This event took place on July 28, 2025, and includes inducement stock options and restricted stock units as part of her compensation.

Quick answer

ImageneBio Appoints Kristin Yarema as Chief Executive Officer (August 1, 2025). ImageneBio is based in San Diego, California, United States.

Who is the new Chief Executive Officer at ImageneBio?
ImageneBio named Kristin Yarema Chief Executive Officer, announced August 1, 2025.
What did ImageneBio announce on August 1, 2025?
ImageneBio granted equity awards to Dr. Kristin Yarema, who was recently appointed as Chief Executive Officer. This event took place on July 28, 2025, and includes inducement stock options and restricted stock units as part of her compensation.
What does ImageneBio do?
ImageneBio is a biopharmaceutical company formed by the merger of Inmagene Biopharmaceuticals and Ikena Oncology.
Where is ImageneBio based?
ImageneBio is based in San Diego, California, United States.
Which similar companies made leadership changes around the same time?
Kodiak Sciences (August 4, 2025), Hansa Biopharma (July 29, 2025), CASI Pharmaceuticals (July 21, 2025) and MacroGenics (August 13, 2025) also announced leadership changes within 45 days of ImageneBio.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biopharma

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at ImageneBio, and when

A new leader at ImageneBio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day ImageneBio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ImageneBio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ImageneBio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ImageneBio

Location

San Diego, California, United States

About

ImageneBio is a biopharmaceutical company formed by the merger of Inmagene Biopharmaceuticals and Ikena Oncology. The company focuses on developing innovative treatments for autoimmune and inflammatory diseases. It operates under the ticker symbol 'IMA' on Nasdaq.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ImageneBio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for ImageneBio's next move

Learn about Strategic plan

ImageneBio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.